期刊
ANTIVIRAL RESEARCH
卷 154, 期 -, 页码 140-148出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2018.04.002
关键词
Adipose tissue; Antiretroviral therapy; CD4 T cells; Dolutegravir; HIV reservoirs; Tenofovir
资金
- NIH/NIAID [R21 AI116208, R33 AI116208, K23 A1110532, RO1 A1124965]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI116208, R33AI116208, K23AI110532, R01AI124965] Funding Source: NIH RePORTER
Adequate distribution of antiretroviral drugs to infected cells in HIV patients is critical for viral suppression. In humans and primates, HIV- and SIV-infected CD4 T cells in adipose tissues have recently been identified as reservoirs for infectious virus. To better characterize adipose tissue as a pharmacological sanctuary for HIV-infected cells, in vitro experiments were conducted to assess antiretroviral drug efficacy in the presence of adipocytes, and drug penetration in adipose tissue cells (stromal-vascular-fraction cells and mature adipocytes) was examined in treated humans and monkeys. Co-culture experiments between HIV-1-infected CD4 T cells and primary human adipocytes showed that adipocytes consistently reduced the antiviral efficacy of the nucleotide reverse transcriptase inhibitor tenofovir and its prodrug forms tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF). In HIV-infected persons, LC-MS/MS analysis of intracellular lysates derived from adipose tissue stromal-vascular-fraction cells or mature adipocytes suggested that integrase inhibitors penetrate adipose tissue, whereas penetration of nucleoside/nucleotide reverse transcriptase inhibitors such as TDF, emtricitabine, abacavir, and lamivudine is restricted. The limited distribution and functions of key antiretroviral drugs within fat depots may contribute to viral persistence in adipose tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据